Renaissance Technologies’s Repros Therapeutics Inc. RPRX Stock Holding History

Renaissance Technologies’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-794,913	Closed	-$525K	–	3780
2017 Q4	$525K	Sell	794,913 -327,100	-29%	-$165K	﹤0.01%	2876
2017 Q3	$359K	Buy	1,122,013 +166,000	+17%	+$58.2K	﹤0.01%	2867
2017 Q2	$440K	Buy	956,013 +228,900	+31%	+$166K	﹤0.01%	2796
2017 Q1	$873K	Buy	727,113 +10,700	+1%	+$13.4K	﹤0.01%	2590
2016 Q4	$946K	Buy	716,413 +49,300	+7%	+$85.7K	﹤0.01%	2559
2016 Q3	$1.39M	Buy	667,113 +105,400	+19%	+$208K	﹤0.01%	2404
2016 Q2	$904K	Buy	561,713 +384,000	+216%	+$737K	﹤0.01%	2579
2016 Q1	$172K	Buy	177,713 +143,800	+424%	+$140K	﹤0.01%	3125
2015 Q4	$41K	Sell	33,913 -10,987	-24%	-$35.3K	﹤0.01%	3194
2015 Q3	$334K	Sell	44,900 -157,243	-78%	-$1.2M	﹤0.01%	2735
2015 Q2	$1.45M	Buy	+202,143	New	+$1.57M	﹤0.01%	2262

Renaissance Technologies's RPRX Position: Q1 2018 in Review

Renaissance Technologies sold out of Repros Therapeutics Inc. (RPRX) in Q1 2018, closing a stake of 794,913 shares — an estimated $525K sold.

Renaissance Technologies first reported a position in RPRX in Q2 2015 and held it in 11 quarters. The position peaked at $1.45M in Q2 2015. 1 fund tracked by Wall St. Rank holds RPRX as of Q1 2018.

Renaissance Technologies reported no remaining Repros Therapeutics Inc. position as of Q1 2018 after selling out during the quarter.
Renaissance Technologies sold 794,913 Repros Therapeutics Inc. shares in Q1 2018, an estimated $525K.
Renaissance Technologies first reported a position in Repros Therapeutics Inc. in Q2 2015 and held it in 11 quarters.
Renaissance Technologies's Repros Therapeutics Inc. position peaked at $1.45M in Q2 2015.
1 fund tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q1 2018.

Based on Renaissance Technologies's 13F filing for Q1 2018, filed 14 May 2018.